The Hatch-Waxman Act of 1984 balanced drug innovation and generic access. It created the ANDA pathway, patent term restoration, and Paragraph IV challenges. Today, generics make up 90% of prescriptions but only 18% of spending. Learn how this law works and its ongoing challenges.